Sort
46,585 grants matching “heart failure”
Early-Stage Chronic Kidney Disease in HIV-infected Individuals
$692,038Gregory M Lucas · Johns Hopkins University · R01 · FY2015 · DA
Novel Pre-Hospital Therapy of Myocardial Infarction
$692,020Asaf Alimardanov · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
Genetically-engineered pig orthotopic (life-supporting) heart transplantation (OHTx) in baboons: establishing consistent graft survival and overcoming rapid post-Tx organ growth
$691,945Muhammad M Mohiuddin · Massachusetts General Hospital · U19 · FY2022 · AI
Endothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertension
$691,933Vinicio A De Jesus Perez · Stanford University · R01 · FY2024 · HL
Alive Blood Pressure Project: A church-based intervention to improve blood pressure
$691,882Elizabeth B Lynch · Rush University Medical Center · R01 · FY2021 · NR
Development of the Predictive NeuroCardiovascular Simulator
$691,875Colleen E Clancy · University Of California At Davis · OT2 · FY2019 · OD
Development of the Predictive NeuroCardiovascular Simulator
$691,874Colleen E Clancy · University Of California At Davis · OT2 · FY2020 · OD
Towards Personalized Prosthetic Graft Replacement for Genetically Triggered Thoracic Aortic Aneurysms
$691,821Jonathan W. Weinsaft · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · HL
Preclinical Diastolic Dysfunction in Type 2 Diabetes
$691,753Horng H Chen · Mayo Clinic Rochester · R01 · FY2019 · HL
Optical Molecular Tomography for Regenerative Medicine
$691,743Ge Wang · Rensselaer Polytechnic Institute · R01 · FY2013 · HL
Control of cancer cachexia via stimulation of resolution of inflammation
$691,696Dipak Panigrahy · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
A Genomic/Metabolomic Strategy to Characterize Cardiac Mitochondrial Dysfunction
$691,570Daniel Patrick Kelly · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · HL
Immune function and the risk of cvd among HIV infected and uninfected veterans
$691,563Matthew S Freiberg · Vanderbilt University Medical Center · R01 · FY2017 · HL
Mechanisms of Right Ventricular Dysfunction in Scleroderma-associated PAH
$691,560Paul M Hassoun · Johns Hopkins University · R01 · FY2019 · HL
Detection and quantification of amyloidosis deposition and circulating amyloid fibrils in asymptomatic carriers of the V122I TTR allele
$691,556Justin Lee Grodin · Ut Southwestern Medical Center · R01 · FY2025 · HL
Validation of Myocardial Oxygen Extraction Fraction Measurement with MRI
$691,547Jie Zheng · Washington University · R01 · FY2025 · HL
Ventricular Vascular Coupling: Correlates and Prognosis
$691,547Vasan S. Ramachandran · Boston University Medical Campus · R01 · FY2006 · HL
Carotid Intraplaque Hemorrhage: MRI of Therapeutic Response and Clinical Sequelae
$691,543Chun Yuan · University Of Washington · R01 · FY2012 · HL
Preclinical Diastolic Dysfunction in Type 2 Diabetes
$691,534Horng H Chen · Mayo Clinic Rochester · R01 · FY2021 · HL
Preclinical Diastolic Dysfunction in Type 2 Diabetes
$691,534Horng H Chen · Mayo Clinic Rochester · R01 · FY2020 · HL
Plasma Sphingolipids and Subclinical and Clinical Cardiovascular Disease
$691,529Rozenn Lemaitre · University Of Washington · R01 · FY2022 · HL
Immunomodulation for Heart Allograft Tolerance
$691,434Richard N Pierson · University Of Maryland Baltimore · U01 · FY2010 · AI
Inhibition of Cardiac Device Induced Cellular Dysfunction in Pigs
$691,377Rekha Bansal · Novelmed Therapeutics, Inc. · R44 · FY2012 · HL
Structural Identification of Prostaglandin Conjugates
$691,361L Jackson Roberts · Vanderbilt University · R37 · FY2008 · GM
New Risk Models for Diabetes Complications Using Electronic Health Records
$691,353Claudia Leonie Nau · Kaiser Foundation Research Institute · R01 · FY2023 · DK